Genmab a dual-listed, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.
We are led by an experienced international management team. Our proprietary product pipeline and next-generation antibody technologies are the result of our strong company culture and a deep passion for innovation. We are inspired by nature and the power of the immune system to transform cancer treatment.
Genmab is focused on the creation and development of innovative and differentiated antibody products, with the aim of improving the lives of cancer patients. Watch this video to learn more about our core values, products, and track record.
